Skip to main content

Advertisement

SpringerLink
Log in

Polyarteritis nodosa revisited

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Polyarteritis nodosa (PAN), the prototype of systemic vasculitis, is a rare condition characterized by necrotizing inflammation of medium-sized or small arteries without glomerulonephritis or vasculitis in arterioles, capillaries, or venules. Signs and symptoms of this disease are primarily attributable to diffuse vascular inflammation and ischemia of affected organs. Virtually any organ with the exception of the lungs may be affected, with peripheral neuropathy and symptoms from osteoarticular, renal artery, and gastrointestinal tract involvement being the most frequent clinical manifestations. A clear distinction between limited versus systemic disease and idiopathic versus hepatitis B related PAN should be done because there are differences in the implicated pathogenetic mechanisms, their treatment, and prognosis. Currently, corticosteroids plus cyclophosphamide is the standard of care for idiopathic PAN, in particular for patients with adverse prognostic factors (more severe disease), in whom this combination prolonged survival. In contrast for hepatitis B related PAN treatment consists of schemes that include plasmapheresis and antiviral agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Tesar V, Kazderova M, Klavackova L: Rokitansky and his first description of polyarteritis nodosa. J Nephrol 2004, 17:172–174.

    PubMed  Google Scholar 

  2. Matteson EL, Kluge FJ: Think clearly, be sincere, act calmly: Adolf Kussmaul (February 22, 1822 – May 28, 1902) and his relevance to medicine in the 21st century. Curr Opin Rheumatol 2003, 15:29–34.

    Article  PubMed  Google Scholar 

  3. Lightfoot RW Jr, Michel BA, Bloch DA, et al.: The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990, 33:1088–1093. American College of Rheumatology criteria for the classification of PAN. The criteria were developed by comparing 118 patients who had this disease with 689 controls who had other forms of vasculitis.

    Article  PubMed  Google Scholar 

  4. Rao JK, Allen NB, Pincus T: Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 1998, 129:345–352. Reinforces the concept that American College of Rheumatology criteria should not be used for diagnosis of vasculitis.

    PubMed  CAS  Google Scholar 

  5. Jennette JC, Falk RJ, Andrassy K, et al.: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187–92. Chapel Hill Consensus Conference: consensus on the names and definitions for the most common forms of noninfectious systemic vasculitis.

    Article  PubMed  CAS  Google Scholar 

  6. Lie JT: Nomenclature and classification of vasculitis: plus ca change, plus c’est la meme chose. Arthritis Rheum 1994, 37:181–186.

    Article  PubMed  CAS  Google Scholar 

  7. Watts RA, Jolliffe VA, Carruthers DM, et al.: Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum 1996, 39:1208–12.

    Article  PubMed  CAS  Google Scholar 

  8. Guillevin L: Polyarteritis nodosa and microscopic polyangiitis. In Vasculitis. Edited by Ball GV, Bridges SL. New York: Oxford University Press; 2002:300–320. Comprehensive review by a leading expert in the study of PAN.

    Google Scholar 

  9. Guillevin L, Lhote F, Cohen P, et al.: Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995, 74:238–253. Description of clinical and biologic characteristics of HBV-related PAN as well as prognostic factors, treatment, and outcomes of the patients.

    Article  CAS  Google Scholar 

  10. Trepo C, Guillevin L: Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun 2001, 16:269–274. Excellent update on HBV-PAN with special reference to its pathogenesis and treatment.

    Article  PubMed  CAS  Google Scholar 

  11. Gonzalez-Gay MA, Garcia-Porrua C: Systemic vasculitis in adults in northwestern Spain, 1988–1997. Clinical and epidemiologic aspects. Medicine (Baltimore) 1999, 78:292–308.

    Article  CAS  Google Scholar 

  12. Watts RA, Lane SE, Bentham G, Scott DG: Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 2000, 43:414–419.

    Article  PubMed  CAS  Google Scholar 

  13. Gonzalez-Gay MA, Garcia-Porrua C, Guerrero J, et al.: The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum 2003, 49:388–393.

    Article  PubMed  Google Scholar 

  14. Mahr A, Guillevin L, Poissonnet M, Ayme S: Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004, 51:92–99.

    Article  PubMed  Google Scholar 

  15. Porter BF, Frost P, Hubbard GB: Polyarteritis nodosa in a cynomolgus macaque (Macaca fascicularis). Vet Pathol 2003, 40:570–573.

    Article  PubMed  CAS  Google Scholar 

  16. Stone JH: Polyarteritis nodosa. JAMA 2002, 288:1632–1639. Case presentation of a patient with PAN that is discussed in the context of the first description by Kussmaul and Maier. Detailed and updated review of the literature.

    Article  PubMed  Google Scholar 

  17. Filer AD, Gardner-Medwin JM, Thambyrajah J, et al.: Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis 2003, 62:162–167.

    Article  PubMed  CAS  Google Scholar 

  18. Chanseaud Y, Pena-Lefebvre PG, Guilpain P, et al.: IgM and IgG autoantibodies from microscopic polyangiitis patients but not those with other small- and medium-sized vessel vasculitides recognize multiple endothelial cell antigens. Clin Immunol 2003, 109:165–178.

    Article  PubMed  CAS  Google Scholar 

  19. Freire Ade L, Bertolo MB, de Pinho AJ Jr, et al.: Increased serum levels of interleukin-8 in polyarteritis nodosa and Behcet’s disease. Clin Rheumatol 2004, 23:203–205.

    Article  Google Scholar 

  20. Coll-Vinent B, Grau JM, Lopez-Soto A, et al.: Circulating soluble adhesion molecules in patients with classical polyarteritis nodosa. Br J Rheumatol 1997, 36:1178–1183.

    Article  PubMed  CAS  Google Scholar 

  21. Soto O, Conn DL: Polyarteritis nodosa and microscopic polyangiitis. In Rheumatology. Edited by Hochberg MC, Silman AJ, Smolen JS, Weimblatt ME, Weisman MH. Mosby; 2003.

  22. Jennette JC: Implications for pathogenesis of patterns of injury in small- and medium-sized-vessel vasculitis. Cleve Clin J Med 2002, 69(Suppl 2):33–38.

    Google Scholar 

  23. Begier EM, Langford CA, Sneller MC, et al.: Polyarteritis nodosa reports to the vaccine adverse event reporting system (VAERS): implications for assessment of suspected vaccineprovoked vasculitis. J Rheumatol 2004, 31:2181–2188. Evaluation of PAN reports to Vaccine Adverse Event Reporting System to test the hypothesis that HBV vaccination can cause PAN. Current adverse event reports do not support a causal link between vaccination and PAN.

    PubMed  Google Scholar 

  24. Agard C, Mouthon L, Mahr A, Guillevin L: Microscopic polyangiitis and polyarteritis nodosa: how and when do they start? Arthritis Rheum 2003, 49:709–715. Retrospective review of 36 patients with biopsy-proven PAN describing the initial clinical manifestations attributable to that vasculitis.

    Article  PubMed  Google Scholar 

  25. Ball GV, Bridges SL: Polyarteritis nodosa. In Arthritis and allied conditions. A textbook in rheumatology. Edited by Koopman WJ, Moreland LW. Philadelphia: Lippincott Williams & Wilkins; 2005:1767–1775.

    Google Scholar 

  26. Younger DS: Vasculitis of the nervous system. Curr Opin Neurol 2004, 17:317–336.

    Article  PubMed  Google Scholar 

  27. de Carvalho Panzeri Carlotti AP, Paes Leme Ferriani V, Tanuri Caldas C, et al.: Polyarteritis nodosa with central nervous system involvement mimicking meningoencephalitis. Pediatr Crit Care Med 2004, 5:286–288.

    Article  PubMed  Google Scholar 

  28. Plumley SG, Rubio R, Alasfar S, et al.: Polyarteritis nodosa presenting as polymyositis. Semin Arthritis Rheum 2002, 31:377–383.

    Article  PubMed  Google Scholar 

  29. Passam FH, Diamantis ID, Perisinaki G, et al.: Intestinal ischemia as the first manifestation of vasculitis. Semin Arthritis Rheum 2004, 34:431–441.

    Article  PubMed  Google Scholar 

  30. Guillevin L, Lhote F, Amouroux J, et al.: Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group. Br J Rheumatol 1996, 35:958–964.

    Article  PubMed  CAS  Google Scholar 

  31. Albert DA, Rimon D, Silverstein MD: The diagnosis of polyarteritis nodosa. I. A literature-based decision analysis approach. Arthritis Rheum 1988, 31:1117–1127.

    Article  PubMed  CAS  Google Scholar 

  32. Heron E, Fiessinger JN, Guillevin L: Polyarteritis nodosa presenting as acute leg ischemia. J Rheumatol 2003, 30:1344–1346.

    PubMed  Google Scholar 

  33. Stanson AW, Friese JL, Johnson CM, et al.: Polyarteritis nodosa: spectrum of angiographic findings. Radiographics 2001, 21:151–159.

    PubMed  CAS  Google Scholar 

  34. Bleeker-Rovers CP, Bredie SJ, van der Meer JW, et al.: Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis. Am J Med 2004, 116:50–53.

    Article  PubMed  Google Scholar 

  35. Langford CA: Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: where do we stand? Arthritis Rheum 2001, 44:508–512.

    Article  PubMed  CAS  Google Scholar 

  36. Guillevin L: Treatment of classic polyarteritis nodosa in 1999. Nephrol Dial Transplant 1999, 14:2077–2079.

    Article  PubMed  CAS  Google Scholar 

  37. Guillevin L, Cohen P, Mahr A, et al.: Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 2003, 49:93–100.

    Article  PubMed  CAS  Google Scholar 

  38. Guillevin L, Lhote F, Gayraud M, et al.: Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996, 75:17–28.

    Article  CAS  Google Scholar 

  39. Gayraud M, Guillevin L, le Toumelin P, et al.: Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001, 44:666–675. Study of the long-term outcome of patients with PAN compared with other vasculitis and the overall French population. Important considerations on prognostic factors, therapy, treatment side effects, and sequelae.

    Article  PubMed  CAS  Google Scholar 

  40. Gayraud M, Guillevin L, Cohen P, et al.: Treatment of goodprognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides. Br J Rheumatol 1997, 36:1290–1297.

    Article  PubMed  CAS  Google Scholar 

  41. Keystone EC: The utility of tumour necrosis factor blockade in orphan diseases. Ann Rheum Dis 2004, 63(Suppl 2):ii79-ii83.

    Article  PubMed  CAS  Google Scholar 

  42. Guillevin L, Mouthon L: Tumor necrosis factor-alpha blockade and the risk of vasculitis. J Rheumatol 2004, 31:1885–1887.

    PubMed  Google Scholar 

  43. Janssen HL, van Zonneveld M, van Nunen AB, et al.: Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome. Eur J Gastroenterol Hepatol 2004, 16:801–807.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. LSU Medical Center, 1542 Tulane Ave., 70112, New Orleans, LA, USA

    Inés Colmegna MD

Authors
  1. Inés Colmegna MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. José A. Maldonado-Cocco MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Colmegna, I., Maldonado-Cocco, J.A. Polyarteritis nodosa revisited. Curr Rheumatol Rep 7, 288–296 (2005). https://doi.org/10.1007/s11926-005-0039-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-005-0039-2

Keywords

Search

Navigation